UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)*

 

 

BIOLASE, INC.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

090911108

(CUSIP Number)

Jack W. Schuler

100 N. Field Drive., Suite 360

Lake Forest, Illinois 60045

(847) 607-2066

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

December 10, 2015

(Date of Event which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

---

SCHEDULE 13D

 

CUSIP No: 090911108		Page 2 of 7 Pages

 

1.		Names of Reporting Persons.   Jack W. Schuler
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a)  ¨        (b)  ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions)   PF
5.		Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)  ¨
6.		Citizenship or Place of Organization   United States
Number of Shares Beneficially Owned by Each Reporting Persons With				7.		Sole Voting Power   0
				8.		Shared Voting Power   11,935,138 (1)
				9.		Sole Dispositive Power   0
				10.		Shared Dispositive Power   11,935,138 (1)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person   11,935,138 (1)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  ¨
13.		Percent of Class Represented by Amount in Row (11)   20.50% (2)
14.		Type of Reporting Person:   IN

 

(1)	Excludes 3,824,252 Shares (as defined herein) underlying warrants that are subject to a blocker restricting their exercise to the extent that the exercise would result in the holder and its affiliates beneficially owning more than 19.99% of the outstanding Shares.

(2)	Based on 58,227,539 Shares outstanding on October 30, 2015.

---

SCHEDULE 13D

 

CUSIP No: 090911108		Page 3 of 7 Pages

 

1.		Names of Reporting Persons.   Jack W. Schuler Living Trust
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a)  ¨        (b)  ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions)   WC
5.		Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)  ¨
6.		Citizenship or Place of Organization   Illinois
Number of Shares Beneficially Owned by Each Reporting Persons With				7.		Sole Voting Power   0
				8.		Shared Voting Power   6,036,873
				9.		Sole Dispositive Power   0
				10.		Shared Dispositive Power   6,036,873
11.		Aggregate Amount Beneficially Owned by Each Reporting Person   6,036,873
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  ¨
13.		Percent of Class Represented by Amount in Row (11)   10.37% (1)
14.		Type of Reporting Person:   OO

 

(1)	Based on 58,227,539 Shares outstanding on October 30, 2015.

---

SCHEDULE 13D

 

CUSIP No: 090911108		Page 4 of 7 Pages

 

1.		Names of Reporting Persons.   Renate Schuler
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a)  ¨        (b)  ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions)   OO
5.		Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)  ¨
6.		Citizenship or Place of Organization   United States
Number of Shares Beneficially Owned by Each Reporting Persons With				7.		Sole Voting Power   0
				8.		Shared Voting Power   5,898,265 (1)
				9.		Sole Dispositive Power   0
				10.		Shared Dispositive Power   5,898,265 (1)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person   5,898,265 (1)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  ¨
13.		Percent of Class Represented by Amount in Row (11)   10.13% (2)
14.		Type of Reporting Person:   IN

 

(1)	Excludes 3,824,252 Shares underlying warrants that are subject to a blocker restricting their exercise to the extent that the exercise would result in the holder and its affiliates beneficially owning more than 19.99% of the outstanding Shares.

(2)	Based on 58,227,539 Shares outstanding on October 30, 2015.

---

SCHEDULE 13D

 

CUSIP No: 090911108		Page 5 of 7 Pages

 

1.		Names of Reporting Persons.   Schuler Family Foundation
2.		Check the Appropriate Box if a Member of a Group (See Instructions) (a)  ¨        (b)  ¨
3.		SEC Use Only
4.		Source of Funds (See Instructions)   WC
5.		Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e)  ¨
6.		Citizenship or Place of Organization   Illinois
Number of Shares Beneficially Owned by Each Reporting Persons With				7.		Sole Voting Power   0
				8.		Shared Voting Power   5,883,465 (1)
				9.		Sole Dispositive Power   0
				10.		Shared Dispositive Power   5,883,465 (1)
11.		Aggregate Amount Beneficially Owned by Each Reporting Person   5,883,465 (1)
12.		Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)  ¨
13.		Percent of Class Represented by Amount in Row (11)   10.10% (2)
14.		Type of Reporting Person:   CO

 

(1)	Excludes 3,824,252 Shares underlying warrants that are subject to a blocker restricting their exercise to the extent that the exercise would result in the holder and its affiliates beneficially owning more than 19.99% of the outstanding Shares.

(2)	Based on 58,227,539 Shares outstanding on October 30, 2015.

---

SCHEDULE 13D

Page 6 of 7 Pages

 

Item 1.

Security and Issuer

This Amendment No. 7 to Schedule 13D (“Amendment No. 7”) is being filed by the undersigned, pursuant to §240.13d-2(a), to amend and supplement the Schedule 13D filed on November 10, 2014, as amended by Amendment No. 1 filed on November 10, 2014, Amendment No. 2 filed on March 6, 2015, Amendment No. 3 filed on October 14, 2015, Amendment No. 4 filed on October 23, 2015, Amendment No. 5 filed on November 9, 2015, and Amendment No. 6 filed on November 13, 2015 (collectively, the “Schedule 13D”), with respect to the common stock, par value $0.001 per share (the “Shares”), of Biolase, Inc. (the “Issuer”), whose principal executive offices are located at 4 Cromwell, Irvine, California 92618. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D.

 

Item 5.

Interest in Securities of the Issuer

Item 5 of the Schedule 13D is hereby amended and supplemented as follows:

(a, b) As of December 10, 2015, Mr. Schuler may be deemed to beneficially own, in the aggregate, 11,935,138 Shares, representing approximately 20.50% of the Shares outstanding. This amount consists of: (A) 6,036,873 Shares held by the Trust, representing approximately 10.37% of the Shares outstanding; (B) 5,883,465 Shares held by the Foundation, representing approximately 10.10% of the Shares outstanding; and (C) 14,800 Shares held by Mr. Schuler’s spouse, Ms. Schuler, representing approximately 0.03% of the Shares outstanding.

As sole trustee of the Trust, Mr. Schuler shares with the Trust the power to vote or direct the vote, and the power to dispose or direct the disposition of, the 6,036,873 Shares held by the Trust. Mr. Schuler disclaims any beneficial ownership in any of the Shares held by the Foundation.

As of December 10, 2015, Ms. Schuler may be deemed to beneficially own, in the aggregate, 5,898,265 Shares, representing approximately 10.13% of the Shares outstanding. This amount consists of (A) 14,800 Shares held by Ms. Schuler, representing approximately 0.03% of the Shares outstanding, and (B) 5,883,465 held by the Foundation, representing approximately 10.10% of the Shares outstanding. Ms. Schuler disclaims any beneficial ownership in any of the Shares held by the Foundation.

The percentages set forth herein are based on 58,227,539 Shares outstanding on October 30, 2015.

As disclosed in Amendment No. 2, the terms of the warrants held by the Foundation prohibit the holder of such warrants from exercising the warrants to the extent that the exercise would result in the holder and its affiliates beneficially owning more than 19.99% of the outstanding Shares. As such, although the Foundation holds warrants to acquire 3,824,252 Shares, due to the 19.99% blocker, at this time, the Foundation cannot exercise any of the warrants.

(c) As of the date hereof, no transactions in the Shares had been effected by the Reporting Persons since the filing of Schedule 13D (Amendment No. 5) on November 9, 2015, other than the following open market purchases:

 

Reporting Person		Date of Transaction		Number of Shares				Price Per Share
Trust		11/11/2015			33,099			$	0.77
Trust		11/12/2015			234,313			$	0.78
Trust		11/13/2015			93,409			$	0.86
Trust		11/16/2015			5,400			$	0.95
Trust		11/17/2015			200			$	0.95
Trust		11/23/2015			64,865			$	0.93
Trust		11/24/2015			100			$	0.92
Trust		11/25/2015			44,200			$	0.90
Trust		11/26/2015			2,045			$	0.89
Trust		11/30/2015			16,752			$	0.90
Trust		12/2/2015			5,900			$	0.85
Trust		12/3/2015			16,427			$	0.81
Trust		12/4/2015			5,286			$	0.81
Trust		12/7/2015			8,561			$	0.80
Trust		12/8/2015			14,596			$	0.79
Trust		12/9/2015			5,704			$	0.79
Trust		12/10/2015			31,699			$	0.78

(d) Except as set forth in this Schedule 13D, to the knowledge of the Reporting Persons, no other person had the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares covered by this Schedule 13D.

(e) Not applicable.

---

SCHEDULE 13D

Page 7 of 7 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

December 14, 2015